Tauquina
A multi-kinase inhibitor indicated for the treatment of FLT3-mutated Acute Myeloid Leukemia (AML) and aggressive systemic mastocytosis in adults.
Therapeutic Area
Onco-Hematology
Active Ingredient
Midostaurine
Line
Hematology + Oncology
Dosage Forms
25 mg hard capsules x 60 and 120 units
